Partner with us to transform West
African healthcare

Most medicines used in the region are imported. Long, cross-border supply chains increase the risk of delays, higher costs, and exposure to substandard or adulterated products. Local pharmaceutical manufacturing keeps production closer to patients and healthcare providers, improving supply reliability, safeguarding medicine quality, and strengthening the overall healthcare system.

BioForma is building regulated pharmaceutical manufacturing capacity designed for specialised and compounded medicines, not just basic generics. We are connecting an active compounding pharmacy with scalable manufacturing infrastructure, creating a clear progression from customised formulations to wider regional supply.

Pharmaceutical demand is growing as healthcare access expands, long-term conditions become more prevalent, and safety standards continue to rise. At the same time, policy and regulatory support for local production is increasing. Together, these shifts create a narrow window to establish safe, compliant manufacturing capacity before the market becomes more crowded.

Pharmaceutical manufacturing at this level depends on more than buildings and equipment. It requires shared expertise, aligned incentives, and long-term commitment. Early partners help shape how this capacity is developed and sustained, while participating in the value it creates over time.